基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Zeiher Bernhardt G. Insider active across 3 companies, notably Amylyx Pharmaceuticals, Inc.. Aggregated, 5 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €59k. History available since 13 August 2024. The latest transaction was disclosed on 20 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Zeiher Bernhardt G is a declarant and a Director at Abeona Therapeutics INC., Entrada Therapeutics, Inc. and Amylyx Pharmaceuticals, Inc. He has 5 filings in total, and among the sampled recent filings, the recorded transactions run from 2024-08-14 to 2026-05-21, with EUR 59130 of buys and EUR 0 of sells. The modal transaction nature listed is Attribution.